Details for 2016771043

Up to date per 04.04.2026

Actions

Title / Product Name

CO-THERAPIE MIT CANAGLIFLOZIN UND PHENTERMIN ZUR VERWENDUNG IN DER BEHANDLUNG VON FETTLEIBIGKEIT UND MIT FETTLEIBIGKEIT ZUSAMMENHÄNGENDEN ERKRANKUNGEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016771043

EP Publication Number

3349740

E-Number

1383901

Language

PCT Number

US16051435

Publication Date

25.07.2018 A

21.04.2021 B1

Registration Date

21.04.2021

AT Publication Date

15.05.2021

Application Date

13.09.2016

Registration Number

Priorities

15.09.2015

201562218842 P

10.03.2016

201662306110 P

12.09.2016

201615262038

IPC

A61K 31/137 20060101AFI20170406BHEP

Maximum Duration of Protection

13.09.2036

Owner

Janssen Pharmaceutica NVTurnhoutseweg 30 2340 BeerseBE

Representative

No representatives present

Inventor

ROSENTHAL, Norman R.920 US Highway 202 S Raritan, New Jersey 08869US

ROTHENBERG, Paul920 US Highway 202 S Raritan, New Jersey 08869US

POLIDORI, David C.3210 Merryfield Row San Diego, California 92121US

WAYS, Douglas K.920 US Highway 202 S Raritan, New Jersey 08869US

STEIN, Peter P.19 Birchwood Court Princeton, New Jersey 08550US